Business News

Billionaires Sell Philip Morris International and Load the Boat on These ‘Magnificent Seven’ Stocks

  • Philip Morris International has had a good year, but the stock has fallen since July on concerns about demand for the company’s smoke-free Zyn products.

  • The tobacco company still pays a relatively high dividend.

  • Several billionaires bought a specific stock of the “Magnificent Seven” in the third quarter.

  • 10 stocks we like better than Alphabet ›

It’s understandable that retail investors see a hedge fund make a large new investment in a company and get excited about the action. After all, billionaire hedge fund managers are generally considered the best stock pickers on Wall Street, and some of them even have a track record of investment returns to back that assumption up.

But retail investors should remember that they typically discover these trades a few months after they occur, and that many hedge funds invest over short-term time horizons. That’s why retail investors should always do their due diligence to make sure it still makes sense to buy a given stock.

However, if multiple billionaire hedge fund managers are buying or selling the same stock, that can be a clear indicator that it’s at least time to consider following their lead. In the third quarter, a number of billionaires sold their stakes in Philip Morris International (NYSE:PM) and loaded onto a “Magnificent Seven” stock.

Image source: Alphabet.

Shares of tobacco giant Philip Morris are having a good year. They were up 27% as of November 17, but the stock had performed even better before that – it has since lost ground since July. And between July and September, a few billionaires gave up their stakes in the company:

  • Stanley Druckenmiller’s Duquesne Family Office sold all of its nearly 816,000 shares.

  • Philippe Laffont’s Coatue Management also completely sold its position in Philip Morris by selling nearly 1.3 million shares.

The stock’s slide began after Philip Morris released its second-quarter earnings report. Its profits were higher than expected and management raised its guidance for the full year. However, revenue fell short of expectations and investors became concerned about demand for the company’s new smokeless nicotine pouch product, Zyn. Demand was still strong, but because Zyn is seen as the future of the long-running cigarette-focused company, investors are focused on its growth.

Investors were spooked again after Philip Morris reported its third-quarter results in late October. Management said it had engaged in some promotions for Zyn, leading some observers to question how sustainable the product’s moat might be in a world of increasing competition. Nonetheless, net revenue from the company’s smoke-free business increased 17.7% year-over-year during the quarter.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button